These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14516332)

  • 21. Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing function.
    Israel CW; Grönefeld G; Iscolo N; Stöppler C; Hohnloser SH
    Pacing Clin Electrophysiol; 2001 Feb; 24(2):183-90. PubMed ID: 11270697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and significance of far-field R wave sensing in a VDD-implantable cardioverter defibrillator.
    Eberhardt F; Schuchert A; Schmitz D; Zerm T; Mitzenheim S; Wiegand UKh;
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):395-403. PubMed ID: 17367360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fuzzy logic-based diagnostic algorithm for implantable cardioverter defibrillators.
    Bárdossy A; Blinowska A; Kuzmicz W; Ollitrault J; Lewandowski M; Przybylski A; Jaworski Z
    Artif Intell Med; 2014 Feb; 60(2):113-21. PubMed ID: 24503486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.
    Friedman PA; Bradley D; Koestler C; Slusser J; Hodge D; Bailey K; Kusumoto F; Munger TM; Militanu A; Glikson M
    Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An adaptive interval-based algorithm for withholding ICD therapy during sinus tachycardia.
    Stadler RW; Gunderson BD; Gillberg JM
    Pacing Clin Electrophysiol; 2003 May; 26(5):1189-201. PubMed ID: 12765446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atrial lead placement in cases of intraoperative atrial fibrillation].
    Driever R; Horlitz M; Müller M; Fuchs S; Gülker H; Vetter H
    Zentralbl Chir; 2003 Apr; 128(4):273-7. PubMed ID: 12700982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia.
    Kouakam C; Kacet S; Hazard JR; Ferraci A; Mansour H; Defaye P; Davy JM; Lambiez M;
    Europace; 2004 Jan; 6(1):32-42. PubMed ID: 14697724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.
    Shurrab M; Janmohamed A; Sarrazin JF; Ayala-Paredes F; Sturmer M; Williams R; Toal S; Lane C; Thorpe KE; Healey JS; Crystal E
    J Interv Card Electrophysiol; 2017 Oct; 50(1):57-63. PubMed ID: 28752228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial lead implantation during atrial flutter or fibrillation?
    Kindermann M; Fröhlig G; Berg M; Lawall P; Schieffer H
    Pacing Clin Electrophysiol; 1998 Aug; 21(8):1531-8. PubMed ID: 9725150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New generation cardioverter-defibrillator lead with a floating atrial sensing dipole: Long-term performance.
    Safak E; D Ancona G; Kaplan H; Caglayan E; Kische S; Öner A; Ince H; Ortak J
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):128-135. PubMed ID: 29222869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinus rhythm R-wave amplitude as a predictor of ventricular fibrillation undersensing in patients with implantable cardioverter-defibrillator.
    Ruetz LL; Koehler JL; Brown ML; Jackson TE; Belk P; Swerdlow CD
    Heart Rhythm; 2015 Dec; 12(12):2411-8. PubMed ID: 26272520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
    Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
    Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator.
    Daoud EG; Nademanee K; Fuenzalida C; Tomassoni GF; Schuger C; Chisner M; Simones M; Schwartz M; Reeve H
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):852-6. PubMed ID: 16903964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arrhythmia detection in single- and dual-chamber implantable cardioverter defibrillators: the more leads, the better?
    Francia P; Balla C; Uccellini A; Cappato R
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1077-82. PubMed ID: 19500231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The atrial defibrillator: a stand-alone device or part of a combined dual-chamber system?
    Heisel A; Jung J
    Am J Cardiol; 1999 Mar; 83(5B):218D-226D. PubMed ID: 10089869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.